Skip to Content
Merck

DNA repair and replication proteins as prognostic markers in melanoma.

Histopathology (2012-10-02)
Liang Song, Tammy Robson, Tamasin Doig, Thomas Brenn, Marie Mathers, Ewan R Brown, Val Doherty, John M S Bartlett, Niall Anderson, David W Melton
ABSTRACT

Elevated expression of DNA repair and replication genes has been reported in thick, non-fixed primary melanomas that subsequently went on to metastasize, when compared to non-recurrent primary tumours. This increased expression could contribute to the extreme resistance shown by melanoma to DNA-damaging chemotherapeutics. We have investigated the hypothesis that levels of key DNA repair and replication proteins are prognostic biomarkers in melanoma. We used a tissue microarray containing samples from all stages of melanomagenesis to investigate the hypothesis that levels of key DNA repair and replication proteins are prognostic biomarkers in a larger, more representative and readily available set of fixed primary melanomas. High expression of topoisomerase IIα (TOP2A), that relieves torsional stress during DNA replication, and XRCC5 (Ku80), required for DNA double-strand break repair, were associated with significantly worse survival. Two (XRCC5 and TOP2A) of seven DNA repair and replication proteins studied were prognostic for melanoma.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-RPA3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution